Stem Cell Reports (Jul 2015)

Distinct Neurodegenerative Changes in an Induced Pluripotent Stem Cell Model of Frontotemporal Dementia Linked to Mutant TAU Protein

  • Marc Ehrlich,
  • Anna-Lena Hallmann,
  • Peter Reinhardt,
  • Marcos J. Araúzo-Bravo,
  • Sabrina Korr,
  • Albrecht Röpke,
  • Olympia E. Psathaki,
  • Petra Ehling,
  • Sven G. Meuth,
  • Adrian L. Oblak,
  • Jill R. Murrell,
  • Bernardino Ghetti,
  • Holm Zaehres,
  • Hans R. Schöler,
  • Jared Sterneckert,
  • Tanja Kuhlmann,
  • Gunnar Hargus

DOI
https://doi.org/10.1016/j.stemcr.2015.06.001
Journal volume & issue
Vol. 5, no. 1
pp. 83 – 96

Abstract

Read online

Frontotemporal dementia (FTD) is a frequent form of early-onset dementia and can be caused by mutations in MAPT encoding the microtubule-associated protein TAU. Because of limited availability of neural cells from patients’ brains, the underlying mechanisms of neurodegeneration in FTD are poorly understood. Here, we derived induced pluripotent stem cells (iPSCs) from individuals with FTD-associated MAPT mutations and differentiated them into mature neurons. Patient iPSC-derived neurons demonstrated pronounced TAU pathology with increased fragmentation and phospho-TAU immunoreactivity, decreased neurite extension, and increased but reversible oxidative stress response to inhibition of mitochondrial respiration. Furthermore, FTD neurons showed an activation of the unfolded protein response, and a transcriptome analysis demonstrated distinct, disease-associated gene expression profiles. These findings indicate distinct neurodegenerative changes in FTD caused by mutant TAU and highlight the unique opportunity to use neurons differentiated from patient-specific iPSCs to identify potential targets for drug screening purposes and therapeutic intervention.